Goat Serum Blocking
Goat Serum Blocking - Related Videos
11:10
Cryopreservation of Preimplantation Embryos of Cattle, Sheep, and Goats
0 Views •
Cited by 23 •
2011
Preimplantation embryos may be cryopreserved after placement into a hypertonic cryoprotective solution to cause cellular dehydration. After equilibration, ice crystal formation is induced in the solution surrounding the embryo. Further dehydration occurs as the embryo is slowly cooled to subzero temperatures before plunging into liquid nitrogen for storage.
07:06
Surgical Technique for the Implantation of a Biomimetic Artificial Intervertebral Disc in a Goat Animal Model
0 Views •
2025
This study presents a novel surgical technique for implanting a biomimetic artificial intervertebral disc (BioAID). The method ensures precise placement and stability, aiming to restore cervical spine function using a goat model. This technique shows promise for clinical application in both human and canine patients suffering from cervical spine myelopathy.
13:21
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
0 Views •
Cited by 6 •
2012
In this study, we describe an improved protocol for a multiplexed high-throughput antibody microarray with lectin detection method that can be used in glycosylation profiling of specific proteins. This protocol features new reliable reagents and significantly reduces the time, cost, and lab equipment requirements as compared to the previous procedure.
06:44
Isolation of Small Noncoding RNAs from Human Serum
0 Views •
Cited by 13 •
2014
This protocol describes a method for extracting small RNAs from human serum. We have used this method to isolate microRNAs from cancer serum for use in DNA arrays and also singleplex quantitative PCR. The protocol utilizes phenol and guanidinium thiocyanate reagents with modifications to yield high quality RNA.
03:52
An Assay to Detect Autoantibodies in Human Serum using a Hippocampal Neuronal Culture
0 Views •
2025
This video demonstrates a technique for identifying antibodies against specific antigens in a sample using a rat hippocampal neuronal culture. By exposing cultured neurons to patient samples containing autoantibodies targeting N-Methyl-D-aspartate receptors (NMDARs), the presence of autoantibodies bound to the neuronal surface is revealed through immunostaining.
FAQs
Proteins in the serum occupy exposed sites that could otherwise attract antibodies nonspecifically. Because these sites become less available before antibody incubation, fewer unintended interactions contribute to the detected signal. The primary antibody can still access its target epitope, so the resulting image or blot typically shows lower background, stronger contrast, and more reliable interpretation.
Serum selection should be considered alongside the species used to produce the primary antibody and the detection system. Researchers often choose serum from a species unrelated to the primary antibody host, helping make the blocking step compatible with the antibody-based assay. This choice is especially important when background signal could obscure specific staining or detection.
The sample type, serum concentration, and incubation period all influence blocking performance. Cells, tissues, membranes, and assay surfaces may expose different numbers or types of nonspecific binding sites, so a condition that works for one preparation may not suit another. Researchers adjust concentration and incubation time to reduce background without compromising access to target epitopes.
Insufficient blocking can leave nonspecific sites available, allowing unintended antibody interactions to increase background signal and reduce contrast. Excessive or poorly matched conditions may also make the assay less effective if target recognition is hindered. Comparing blocking conditions helps researchers identify a balance that preserves specific detection while limiting misleading signal in the biological sample.
The serum treatment is performed before antibody-based detection, after selecting a concentration and incubation period appropriate for the sample and detection system. The prepared cells, tissue, membrane, or assay surface receives the blocking step before exposure to the primary antibody. This sequence limits nonspecific interactions during the subsequent immunostaining or assay measurements.
Goat serum blocking can support immunohistochemistry, immunofluorescence, Western blotting, and related antibody-based analyses. Its role remains consistent across these formats, but the relevant sample may differ, ranging from tissue sections and cells to membranes or other assay surfaces. Applying the step within the appropriate workflow can improve signal interpretation across diverse biological experiments.
A successful blocking condition makes the detected pattern easier to distinguish from background, improving confidence that observed signal reflects antibody recognition rather than nonspecific binding. In immunofluorescence or immunohistochemistry, this supports clearer localization in cells or tissues. In Western blotting and related assays, it contributes to more dependable interpretation of antibody-dependent signals.
Condition selection should begin with the sample’s physical format and the assay’s detection system, then account for the serum concentration and incubation period. Researchers can optimize these parameters for cells, tissues, membranes, or assay surfaces rather than treating them as interchangeable. The practical goal is to lower background while maintaining access to the epitopes required for specific antibody detection.